Wockhardt’s Zaynich Receives Regulatory Approval: A Potential Blockbuster for the Indian Pharma Sector
Wockhardt’s Zaynich receives regulatory approval in India and is seeking approval in Europe, with the US FDA granting priority review and QIDP designations. The commercial success of this innovative product has the potential to significantly impact the company’s long-term outlook and the Indian pharmaceutical sector.